Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114656347B reveals efficient palladium-catalyzed synthesis. Offers high deuteration rates and scalable routes for pharmaceutical intermediates supply chain optimization.
Novel patent CN114751883B enables efficient one-step synthesis. Delivers supply chain stability and cost optimization for global pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed bis-carbonylation route offers high yields and broad substrate scope for bioactive scaffold manufacturing.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Novel nickel-catalyzed carbonylation method for indole synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates significantly.
Novel Pd-catalyzed bis-carbonylation method offers high yields and scalability for bioactive furanone production, significantly reducing manufacturing costs.
Patent CN117164534A reveals a novel Pd-catalyzed carbonylation route for benzofuran derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel reductive aminocarbonylation route using nitroarenes offers high yields and broad substrate tolerance for complex pharmaceutical intermediate manufacturing.
Patent CN114751883B reveals a novel Pd-catalyzed carbonylation route for benzofuran-3-carboxamide, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel palladium-catalyzed carbonylation method for quinoline-4(1H)-one. Enhances purity, reduces cost, ensures supply chain reliability for pharmaceutical intermediates.
Patent CN111423381B reveals a mild Pd-catalyzed route for 2-trifluoromethyl imidazoles, offering cost-effective API intermediate manufacturing with high substrate tolerance.
Patent CN112898192B details a novel Pd-catalyzed carbonylative cyclization for N-acyl indoles, offering cost reduction in API manufacturing and scalable production.
Patent CN115286628B reveals efficient palladium catalyzed carbonylation for high purity indolo isoquinoline intermediates offering significant supply chain and cost advantages.
Patent CN115286553B reveals nickel-catalyzed carbonylation for indole synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel cobalt-catalyzed C-H activation method for tetrahydro-beta-carbolinones. High yields, scalable process for API intermediates replacing palladium.
Patent CN112321593B details a novel cobalt-catalyzed carbonylation route for indolo[1,2-a]quinazolin-6(5H)-ones, offering a cost-effective alternative to palladium methods for pharmaceutical intermediates.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation route for tetrahydro-beta-carbolinones, offering a cost-effective alternative to palladium methods for API intermediates.
Patent CN115260080B reveals efficient Pd-catalyzed carbonylation for indole-3-carboxamide. Offers cost reduction and scalable supply for pharmaceutical intermediates.
Novel cobalt catalyzed carbonylation method offers cost effective scalable production for pharmaceutical intermediates ensuring high purity and supply continuity
Novel Pd-catalyzed carbonylation method for indolo[2,1a]isoquinoline. High efficiency, scalable process for pharmaceutical intermediates supply chain optimization.